Biotech

All Articles

Zephyrm seeks Hong Kong IPO to finance phase 3 tissue therapy tests

.Zephyrm Bioscience is gusting towards the Hong Kong stock exchange, submission (PDF) for an IPO to ...

Frazier Lifestyle Sciences collects $630M for small, mid-cap biotechs

.Frazier Lifespan Sciences has sourced an additionally $630 million for its fund focused on tiny as ...

GigaGen garners as much as $135M BARDA dollars to hammer botox

.Antitoxin aficionado GigaGen, a subsidiary of Spanish biopharma Grifols, is increase its own techni...

GPCR organization Septerna declare IPO on stamina of preclinical information

.Septerna is about to determine exactly how a biotech without "any sort of purposeful clinical data"...

Kurma shuts initially $154M haul for most significant biotech fund yet

.European VC agency Kurma Partners has actually introduced its latest biotech fund, along with 140 m...

Prothena ensures one exec while an additional keeps-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our summary of notable leadership hirings, shootings as ...

Editas profit Tip Cas9 licensing rights for $57M

.Against the scenery of a Cas9 license struggle that declines to die, Editas Medication is moneying ...

Ultragenyx tweaks gene therapy dosing to call up efficiency

.A minority of individuals taking Ultragenyx Drug's Wilson ailment genetics treatment UX701 have act...

Biopharma cutback fee maintains in Q3: Tough Biotech study

.As summer months heat energy turns to cool down winds, hopes that this year will bring common marke...

J &amp J drops stage 2 dengue applicant in most up-to-date shift from vaccinations

.Johnson &amp Johnson's deprioritization of its contagious health condition pipe has actually profes...